# Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient

> **NCT05339009** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Kidney Disease 5D

## Interventions

- **BIOLOGICAL:** BioADM determination in plasma

## Key facts

- **NCT ID:** NCT05339009
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-05-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05339009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05339009, "Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT05339009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*